A proteomic approach to identifying novel determinants of tumour response to chemotherapy in colorectal cancer
Colorectal cancer (CRC)is the leading cause of cancer-related deaths in the western world. In the metastatic setting, less than half of patients who undergo chemotherapy will receive any , ...' benefit from treatment. A major factor limiting the 'effectiveness of chemotherapy is .acquired...
Main Author: | Wilson, P. M. D. |
---|---|
Published: |
Queen's University Belfast
2008
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.487468 |
Similar Items
-
Identification of predictive markers of response to chemotherapy in advanced colorectal cancer
by: Coyle, V.
Published: (2010) -
Identification of tumour-specific T-cells in colorectal cancer patients
by: Robinson, Jonathan Matthew
Published: (2006) -
Serum protein profiling using a proteomics approach in the diagnosis of colorectal cancer
by: Ward, Nicholas
Published: (2009) -
Establishing a genotoxic predictive test of toxicities and response to irinotecan chemotherapy in metastatic colorectal cancer
by: Wood, Joanna Peta
Published: (2012) -
The role of ADAM 17 in regulating resistance to Chemotherapy Treatment in Colorectal Cancer
by: Doherty, J. E.
Published: (2010)